Executive summary: The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs | Rheumatology | Oxford Academic
This guideline offers systematic and evidence-based recommendations to support UK clinicians in the prescription of bDMARD and tsDMARD therapies in adult patients with PsA. To read the full article, choose Open Athens “Institutional Login” and search for “Midlands Partnership”.
